Suppr超能文献

1991 - 2004年HIV感染女性鳞状上皮内病变的决定因素与演变

Determinants and evolution of squamous intraepithelial lesions in HIV-infected women, 1991-2004.

作者信息

Drogoul-Vey M-P, Marimoutou C, Robaglia-Schlupp A, Beerli M, Gastaut J-A, Cau P, Poizot-Martin I

机构信息

CISIH-Sud, Hôpital Sainte-Marguerite, Marseille, France.

出版信息

AIDS Care. 2007 Sep;19(8):1052-7. doi: 10.1080/09540120701295242.

Abstract

This study presents a case-control nested analysis of cervical squamous intraepithelial lesions (SIL) in a cohort of 423 HIV-infected women with registered Pap smears between 1991 and 2004. Data on Pap smear results, CDC HIV classification, CD4 cell count and antiretroviral therapy were prospectively collected. Pap smears were classified using the Bethesda classification. Women had a median of three Pap smears registered in the database. The first Pap smear was registered <or=1996 for 57.7%. Two hundred and twenty women were diagnosed with SIL at least once, mainly at their first screening. Compared to women free of SIL and cancer at all Pap smear, they were younger, had lower CD4 cell count and were more likely included <or=1996 and less likely treated with HAART. These differences persisted in multivariate analysis. Among the 142 women with secondary Pap smears after SIL diagnosis, 43 (30.3%) worsen their Pap smear results. No specific characteristics could be identified for these patients compared to those who did not. Finally 21 women were diagnosed with cervix cancer, three at first Pap smear and the others after a previous SIL diagnosis in a median delay of three years. These results reflect the change in gynaecologic management of HIV-infected women after HAART introduction but also underline the necessity to maintain a regular gynaecologic screening for HIV-infected women.

摘要

本研究对1991年至2004年间423名有巴氏涂片登记记录的HIV感染女性队列中的宫颈鳞状上皮内病变(SIL)进行了病例对照巢式分析。前瞻性收集了巴氏涂片结果、美国疾病控制与预防中心(CDC)的HIV分类、CD4细胞计数和抗逆转录病毒治疗的数据。巴氏涂片采用贝塞斯达分类法进行分类。女性在数据库中登记的巴氏涂片中位数为3次。57.7%的女性首次巴氏涂片登记时间≤1996年。220名女性至少有一次被诊断为SIL,主要是在首次筛查时。与所有巴氏涂片均无SIL和癌症的女性相比,她们更年轻,CD4细胞计数更低,更有可能在≤1996年被纳入研究,且接受高效抗逆转录病毒治疗(HAART)的可能性更小。这些差异在多变量分析中仍然存在。在142名SIL诊断后有二次巴氏涂片的女性中,43名(30.3%)巴氏涂片结果恶化。与未恶化的患者相比,这些患者没有可识别的特定特征。最后,21名女性被诊断为宫颈癌,3名在首次巴氏涂片时被诊断,其他患者在先前SIL诊断后的中位延迟三年后被诊断。这些结果反映了HAART引入后HIV感染女性妇科管理的变化,但也强调了对HIV感染女性进行定期妇科筛查的必要性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验